Dr. Babak Samimi, MD

Dr. Samimi practices at Samimi Orthopedic Group, Inc. in West Covina, California.

Dr. Samimi's NPI, 1912121377, was assigned on April 13, 2007. Dr. Samimi graduated from David Geffen School of Medicine at UCLA in 2004. Dr. Samimi holds California license A93747.

Dr. Samimi's primary practice is Samimi Orthopedic Group, Inc., at 741 S Orange Ave, West Covina, CA 91790 in Los Angeles County. The practice phone is (626) 338-7391.

Dr. Samimi's primary practice is Samimi Orthopedic Group, Inc. in West Covina, California. The medical group on file is Samimi Orthopedic Group. Dmand AI also links Dr. Samimi to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Samimi practices, 2 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Samimi's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Samimi is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dr. Samimi is licensed in California.

Dmand AI lists arthritis, broken or dislocated ankle/ or foot, bursitis, carpal tunnel syndrome, chest wall injury, enthesopathy in arms, fluid in a joint and hand joint or tendon inflammation among the conditions Dr. Samimi treats.

CMS data shows 8,468 Medicare services from Dr. Samimi across 20 procedure codes in 2024, for 309 Medicare patients. Medicare paid $136,951 for them. Every service was in an office.

CMS counts 309 Medicare patients who saw Dr. Samimi in 2024. The largest group is 65 to 74, with 133 patients. 75% of them have arthritis, and 75% have high blood pressure. 51% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Samimi's median patient age at 63, with 57% women.

In 2024, Dr. Samimi wrote 148 Medicare Part D claims for 79 patients. 99% of them were for generic drugs. CMS names the drug for 96 of them, across 4 drugs with 11 or more claims each, at $564 in total drug cost. In 2023, CMS named 103 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Samimi for performance year 2024, reported individually. Dr. Samimi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Samimi as offering telehealth.

Knee replacement: 1 to 10 procedures (CMS shows small counts as a range)

Lower limb (leg) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Upper limb (arm) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. Samimi to 1 clinical trial.

CMS Open Payments shows 404 general payments to Dr. Samimi from 24 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 79% of the total. Arthrex, Inc. paid the most, $265,884.

Dmand AI lists 3 awards for Dr. Samimi, most recently CMS Stage 1 EHR in 2011.

Dr. Samimi graduated from David Geffen School of Medicine at UCLA in 2004.

Dr. Samimi is in network with 17 carriers, including Elevance, United Healthcare and Aetna. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.